{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:25:47Z","timestamp":1777530347333,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 110-2314-B-303-008"],"award-info":[{"award-number":["MOST 110-2314-B-303-008"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["108-2314-B-303 -005 -MY2"],"award-info":[{"award-number":["108-2314-B-303 -005 -MY2"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005925","name":"Buddhist Tzu Chi Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022298","name":"Hualien Tzu Chi Hospital Buddhist Tzu Chi Medical Foundation","doi-asserted-by":"publisher","award":["TCRD109-02E"],"award-info":[{"award-number":["TCRD109-02E"]}],"id":[{"id":"10.13039\/501100022298","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022298","name":"Hualien Tzu Chi Hospital Buddhist Tzu Chi Medical Foundation","doi-asserted-by":"publisher","award":["TCRD111-041"],"award-info":[{"award-number":["TCRD111-041"]}],"id":[{"id":"10.13039\/501100022298","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022298","name":"Hualien Tzu Chi Hospital Buddhist Tzu Chi Medical Foundation","doi-asserted-by":"publisher","award":["TCMF-CP 111-01"],"award-info":[{"award-number":["TCMF-CP 111-01"]}],"id":[{"id":"10.13039\/501100022298","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.yexcr.2022.113323","type":"journal-article","created":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T18:47:48Z","timestamp":1661626068000},"page":"113323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effect of ovulation IGF and HGF signaling on the oncogenesis of murine epithelial ovarian cancer cell ID8"],"prefix":"10.1016","volume":"419","author":[{"given":"Tang-Yuan","family":"Chu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Chao","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aye Aye","family":"Khine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pao-Chu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Hsun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsuan-Shun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2022.113323_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.yexcr.2022.113323_bib2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ajpath.2020.09.006","article-title":"The origin of ovarian cancer species and precancerous landscape","volume":"191","author":"Shih","year":"2021","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.yexcr.2022.113323_bib3","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0002-9440(10)63708-X","article-title":"Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis","volume":"164","author":"Shih Ie","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.yexcr.2022.113323_bib4","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ajpath.2015.11.011","article-title":"The dualistic model of ovarian carcinogenesis: revisited, revised, and expanded","volume":"186","author":"Kurman","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.yexcr.2022.113323_bib5","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3389\/fonc.2018.00654","article-title":"When is \"type I\" ovarian cancer not \"type I\"? Indications of an out-dated dichotomy","volume":"8","author":"Salazar","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.yexcr.2022.113323_bib6","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/oxfordjournals.aje.a115076","article-title":"Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and oral contraceptive use","volume":"128","author":"Wu","year":"1988","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.yexcr.2022.113323_bib7","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1158\/0008-5472.CAN-19-2850","article-title":"The risk of ovarian cancer increases with an increase in the lifetime number of ovulatory cycles: an analysis from the ovarian cancer cohort consortium (OC3)","volume":"80","author":"Trabert","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2022.113323_bib8","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/aje\/kwi162","article-title":"Short-term oral contraceptive use and the risk of epithelial ovarian cancer","volume":"162","author":"Greer","year":"2005","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.yexcr.2022.113323_bib9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/AOG.0b013e318291c235","article-title":"Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and meta-analysis","volume":"122","author":"Havrilesky","year":"2013","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.yexcr.2022.113323_bib10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1525-1438.2007.00804.x","article-title":"Age at first birth, parity, and risk of death from ovarian cancer in Taiwan: a country of low incidence of ovarian cancer","volume":"17","author":"Yang","year":"2007","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.yexcr.2022.113323_bib11","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0090-8258(03)00088-X","article-title":"Risk factors for ovarian cancer in Taiwan: a case-control study in a low-incidence population","volume":"89","author":"Yen","year":"2003","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.yexcr.2022.113323_bib12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/CEJ.0000000000000217","article-title":"Ovarian cancer: epidemiology and risk factors","volume":"26","author":"La Vecchia","year":"2017","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.yexcr.2022.113323_bib13","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/carcin\/21.4.585","article-title":"Development of a syngeneic mouse model for events related to ovarian cancer","volume":"21","author":"Roby","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.yexcr.2022.113323_bib14","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.1158\/0008-5472.CAN-16-1272","article-title":"CRISPR\/Cas9-Mediated Trp53 and Brca2 knockout to generate improved murine models of ovarian high-grade serous carcinoma","volume":"76","author":"Walton","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2022.113323_bib15","first-page":"1317","article-title":"Characterization and evaluation of pre-clinical suitability of a syngeneic orthotopic mouse ovarian cancer model","volume":"33","author":"Cho","year":"2013","journal-title":"Anticancer Res."},{"key":"10.1016\/j.yexcr.2022.113323_bib16","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.7150\/jca.60120","article-title":"Insulin-like growth factor-2 (IGF2) and hepatocyte growth factor (HGF) promote lymphomagenesis in p53-null mice in tissue-specific and estrogen-signaling dependent manners","volume":"12","author":"Huang","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.yexcr.2022.113323_bib17","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ebiom.2019.01.061","article-title":"IGF-axis confers transformation and regeneration of fallopian tube fimbria epithelium upon ovulation","volume":"41","author":"Hsu","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.yexcr.2022.113323_bib18","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.neo.2021.09.006","article-title":"Ovulation sources coagulation protease cascade and hepatocyte growth factor to support physiological growth and malignant transformation","volume":"23","author":"Huang","year":"2021","journal-title":"Neoplasia"},{"key":"10.1016\/j.yexcr.2022.113323_bib19","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1093\/carcin\/bgv132","article-title":"Mutagenic, surviving and tumorigenic effects of follicular fluid in the context of p53 loss: initiation of fimbria carcinogenesis","volume":"36","author":"Huang","year":"2015","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.yexcr.2022.113323_bib20","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1158\/1078-0432.CCR-14-2518","article-title":"Molecular pathways: clinical applications and future direction of insulin-like growth factor-1 receptor pathway blockade","volume":"21","author":"Iams","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexcr.2022.113323_bib21","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1177\/1758834011422556","article-title":"An overview of the c-MET signaling pathway","volume":"3","author":"Organ","year":"2011","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.yexcr.2022.113323_bib22","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ygyno.2005.09.052","article-title":"Expression of Wilms tumor gene (WT1) in epithelial ovarian cancer","volume":"101","author":"Hylander","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.yexcr.2022.113323_bib23","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ctrv.2017.08.012","article-title":"IGF system targeted therapy: therapeutic opportunities for ovarian cancer","volume":"60","author":"Liefers-Visser","year":"2017","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.yexcr.2022.113323_bib24","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0002-9440(10)65130-9","article-title":"Comparison of c-met expression in ovarian epithelial tumors and normal epithelia of the female reproductive tract by quantitative laser scan microscopy","volume":"155","author":"Huntsman","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.yexcr.2022.113323_bib25","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.3892\/ol.2016.4895","article-title":"c-met is overexpressed in type I ovarian cancer: results of an investigative analysis in a cohort of consecutive ovarian cancer patients","volume":"12","author":"Battista","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.yexcr.2022.113323_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/srep38502","article-title":"c-MET as a potential therapeutic target in ovarian clear cell carcinoma","volume":"6","author":"Kim","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexcr.2022.113323_bib27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.tjog.2018.11.020","article-title":"Clinical significance of c-Met and phospho-c-Met (Tyr1234\/1235) in ovarian cancer","volume":"58","author":"Lim","year":"2019","journal-title":"Taiwan. J. Obstet. Gynecol."},{"key":"10.1016\/j.yexcr.2022.113323_bib28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ygyno.2011.06.016","article-title":"The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinoma","volume":"123","author":"King","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.yexcr.2022.113323_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-53322-y","article-title":"Dual targeting of IGF-1R and ErbB3 as a potential therapeutic regimen for ovarian cancer","volume":"9","author":"Camblin","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexcr.2022.113323_bib30","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ygyno.2005.09.048","article-title":"Insulin-like growth factor receptor I targeting in epithelial ovarian cancer","volume":"100","author":"Gotlieb","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.yexcr.2022.113323_bib31","first-page":"6125","article-title":"The anti-tumor effect of cabozantinib on ovarian clear cell carcinoma in vitro and in vivo","volume":"37","author":"Nakatani","year":"2017","journal-title":"Anticancer Res."},{"key":"10.1016\/j.yexcr.2022.113323_bib32","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13029","article-title":"Cellular models of development of ovarian high-grade serous carcinoma: a review of cell of origin and mechanisms of carcinogenesis","volume":"54","author":"Mei","year":"2021","journal-title":"Cell Prolif"},{"key":"10.1016\/j.yexcr.2022.113323_bib33","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/path.4807","article-title":"Haemoglobin in pelvic fluid rescues Fallopian tube epithelial cells from reactive oxygen species stress and apoptosis","volume":"240","author":"Huang","year":"2016","journal-title":"J. Pathol."},{"key":"10.1016\/j.yexcr.2022.113323_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13030468","article-title":"Ovulatory follicular fluid facilitates the full transformation process for the development of high-grade serous carcinoma","volume":"13","author":"Hsu","year":"2021","journal-title":"Cancers (Basel)"}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482722003160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482722003160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:42:31Z","timestamp":1777394551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482722003160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0014482722003160"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2022.113323","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of ovulation IGF and HGF signaling on the oncogenesis of murine epithelial ovarian cancer cell ID8","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2022.113323","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113323"}}